143 related articles for article (PubMed ID: 8894744)
1. Development of secondary leukemia associated with (1;7)(q10;p10) in a patient with Crow-Fukase syndrome.
Satoh K; Miura I; Chubachi A; Utsumi S; Imai H; Miura AB
Intern Med; 1996 Aug; 35(8):660-2. PubMed ID: 8894744
[TBL] [Abstract][Full Text] [Related]
2. Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6).
Obara N; Shinagawa A; Komatsu T; Abe T; Ninomiya H
Cancer Genet Cytogenet; 1999 Nov; 115(1):62-4. PubMed ID: 10565302
[TBL] [Abstract][Full Text] [Related]
3. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
[TBL] [Abstract][Full Text] [Related]
4. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
[TBL] [Abstract][Full Text] [Related]
5. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
6. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
7. Unbalanced 1;7 translocation in myelodysplastic syndrome following treatment of acute myeloblastic leukemia with an 8;21 translocation.
Hamamoto K; Hashimoto-Ninomiya A; Kishimoto Y; Kimura T; Fujitake H; Yasunaga K; Horiike S
Cancer Genet Cytogenet; 1994 May; 74(1):35-9. PubMed ID: 8194045
[TBL] [Abstract][Full Text] [Related]
8. [Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Kawakami K; Watanabe Y; Kadowaki S
Rinsho Ketsueki; 2003 Mar; 44(3):168-73. PubMed ID: 12722343
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
So CC; Ma ES; Wan TS; Yip SF; Chan LC
Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
[No Abstract] [Full Text] [Related]
10. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
Matano S; Kobayashi K; Nakamura S; Yoshida T
Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
[TBL] [Abstract][Full Text] [Related]
11. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study.
Lim G; Oh SH; Choi JR; Lee HJ; Suh JT; Yoon HJ; Lee S; Lee WI; Park TS
Leuk Res; 2010 Aug; 34(8):e208-9. PubMed ID: 20299095
[No Abstract] [Full Text] [Related]
12. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.
Bennett JM; Moloney WC; Greene MH; Boice JD
Hematol Pathol; 1987; 1(2):99-104. PubMed ID: 3504435
[TBL] [Abstract][Full Text] [Related]
14. Partial trisomy 1q, an uncommon chromosomal aberration in erythroleukemia.
Baumgarten E; Wegner RD; Fengler R; Koch H; Henze G
Leuk Lymphoma; 1993 Jun; 10(3):237-40. PubMed ID: 8220123
[TBL] [Abstract][Full Text] [Related]
15. IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).
Westman MK; Pedersen-Bjergaard J; Andersen MT; Andersen MK
Leukemia; 2013 Apr; 27(4):957-9. PubMed ID: 23192014
[No Abstract] [Full Text] [Related]
16. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
17. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
[TBL] [Abstract][Full Text] [Related]
18. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
Hsiao HH; Sashida G; Ito Y; Kodama A; Fukutake K; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
[TBL] [Abstract][Full Text] [Related]
19. Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation.
Papaioannou G; Batsis I; Iordanidis F; Vadikoliou C; Kaloyannidis P; Anagnostopoulos A; Athanasiadou A
Hematol Oncol; 2011 Sep; 29(3):161-3. PubMed ID: 21922511
[No Abstract] [Full Text] [Related]
20. Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10).
Wang L; Ogawa S; Hangaishi A; Qiao Y; Hosoya N; Nanya Y; Ohyashiki K; Mizoguchi H; Hirai H
Blood; 2003 Oct; 102(7):2597-604. PubMed ID: 12816870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
